Fda (original) (raw)

Latest News for: fda

Edit

Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA

CBS News 09 Jun 2026

There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports ... .

Edit

New cancer risk tool that flags patients early seeks FDA approval

Newsweek 09 Jun 2026

A new tool that identifies early cancer risk in patients is currently under review with the Food and Drug Administration (FDA), the company that developed the device informed Newsweek, ...

Edit

Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use

The Joplin Globe 09 Jun 2026

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 9, 2026-- ... .

Edit

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in ...

Nasdaq Globe Newswire 09 Jun 2026

Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – ... .

Edit

Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation ...

Nasdaq Globe Newswire 09 Jun 2026

Atavistik Bio announces U.S. FDA clearance of investigational new drug application and Fast Track Designation for ATV-601 for the treatment of HHT ... .

Edit

US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences’ Dual Signal ...

The Joplin Globe 09 Jun 2026

PALO ALTO, Calif.--(BUSINESS WIRE)--Jun 9, 2026-- ... .

Edit

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Nasdaq Globe Newswire 09 Jun 2026

Matisse obtains FDA Fast Track Designation for isupartob sodium in sepsis. FDA's Fast Track is designed to get important new drugs to the patient earlier ... .

Edit

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

Nasdaq Globe Newswire 09 Jun 2026

Issued on behalf of Conexeu Sciences Inc. Issued on behalf of Conexeu Sciences Inc ... .

Edit

Multi Radiance Medical Expands FDA-Cleared Indications with New Lateral Epicondylitis Clearance Following Successful Triple-Blind Clinical Trial

Times Argus 09 Jun 2026

SOLON, Ohio--(BUSINESS WIRE)--Jun 9, 2026-- ....

Edit

FDA Approves the First New Sunscreen Ingredient in 20 Years

Time Magazine 09 Jun 2026

Bemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe for years. .

Edit

FDA OKs first new sunscreen ingredient in more than 25 years

Lancaster Online 09 Jun 2026

market in more than 25 years.

Edit

U.S. FDA approves new sunscreen ingredient used for years in Europe and Asia

CTV 09 Jun 2026

.

Edit

FDA green-lights 1st new sunscreen ingredient in years

ABC7 09 Jun 2026

The Food and Drug Administration is green-lighting a new sunscreen ingredient. .

Edit

NBC News 09 Jun 2026

The Food and Drug Administration on Tuesday expanded its list of allowed sunscreen ingredients to include the chemical compound bemotrizinol ... .

Edit

Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T ...

Nasdaq Globe Newswire 09 Jun 2026

Approval paves the way for CTA313 clinical study in the United States ...